Interest of Virtual Reality Headset During Injection in Patients With Back Pain and Sciatica
Epi-RéV
Evaluation of the Interest of a Virtual Reality Headset on Pain and Anxiety During Epidural Injection Through the Sacrococcygeal Hiatus in Patients With Lumbar Radicular Pain.
1 other identifier
interventional
116
1 country
1
Brief Summary
For a few years, publications have been published concerning the use of virtual reality headsets in the field of medicine and particularly in various specialities. It has been evaluated in different studies on pain and anxiety in various medical situations. A study has shown a correlation between a decrease in pain in a clinical way during a painful stimulation and a decrease in certain areas of the brain. In this context, the use of the virtual reality headset could then be used in medical interventions that may be painful for the patient. The lumbar radicular pain is a common disease in the world. The epidural injection is one of the treatment of this pathology. He may be performed to reduce the pain but sometimes this act is painful. Most of the time this procedure is performed without premedication. To the knowledge of the investigators, there are currently no studies on the assessment of pain under a virtual reality headset during the performance of an epidural injection in rheumatology. The aim of the study is to demonstrate that the Virtual Reality Headset can reduce the pain and the anxiety during an epidural injection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2022
CompletedFirst Submitted
Initial submission to the registry
August 16, 2022
CompletedFirst Posted
Study publicly available on registry
August 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2024
CompletedJanuary 21, 2026
January 1, 2024
7 months
August 16, 2022
January 19, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
State-Trait Anxiety Inventory
State-Trait Anxiety Inventory STAI-B (trait anxiety), STAI-A (state anxiety)
Day 1
State-Trait Anxiety Inventory
STAI-B (trait anxiety), STAI-A (state anxiety)
Day 3
Study Arms (2)
virtual reality - Day1
EXPERIMENTALUse of the virtual reality headset during the first epidural infiltration (Day 1). The second infiltration (Day 3) will be performed without the virtual reality headset.
virtual reality - Day3
EXPERIMENTALFirst epidural infiltration without the virtual reality headset (day 1). The second infiltration will be performed with the virtual reality headset (Day 3).
Interventions
Virtual Reality Headset of the society Healthy Mind and is a CE Class 1 medical device. This virtual reality headset is a Pico G2 4K and corresponds to the model A7510 and is connected to a Bose Sound Link 2 AE headset.
Eligibility Criteria
You may qualify if:
- Patient aged 18-90 years,
- Diagnosed with lomboradiculalgia requiring two epidural injection through the sacrococcygeal hiatus,
- Hospitalized in the Rheumatology Department of the University Hospital of Reims,
- Speak French language.
- Affiliated or beneficiary of a social security scheme
- Having given their written agreement to participate in the study (signature of the consent form)
You may not qualify if:
- Profound or total deafness,
- Visually impaired,
- Presence of contraindication to injection,
- Inability to answer the questionnaire due to severe cognitive impairment,
- Injection with and without virtual reality headset not performed by the same person,
- Vestibular pathologies,
- Epilepsy,
- Claustrophobia,
- Use of nitrous oxide for injection.
- Premedication for infiltration (analgesic, anxiolytic)
- Patients under guardianship, curatorship, safeguard of justice
- Pregnant women
- Psychotic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Chu Reims
Reims, 51092, France
Related Publications (1)
Javelot M, Chopin C, Bolko L, Hittinger A, Geoffroy M, Charlot I, Adeline F, Coutureau C, Duvivier A, Salmon JH. Effect of Virtual Reality on Pain and Anxiety During Epidural Steroid Injection in Patients with Lumbar Radicular Pain: An Open-Label Randomized Trial. Healthcare (Basel). 2025 Sep 22;13(18):2376. doi: 10.3390/healthcare13182376.
PMID: 41008506RESULT
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2022
First Posted
August 18, 2022
Study Start
August 8, 2022
Primary Completion
February 22, 2023
Study Completion
January 12, 2024
Last Updated
January 21, 2026
Record last verified: 2024-01